Table 2.
The number and proportion of scans done to investigate metastases of prostate cancer from 2005 to 2016 relative to the number of patients in each 2-year group.
| Yr | 2005–2006 | 2007–2008 | 2009–2010 | 2011–2012 | 2013–2014 | 2015–2016 |
|---|---|---|---|---|---|---|
| CT scan (%) | 26 (36.6) | 68 (42.5) | 74 (45.1) | 83 (52.2) | 67 (46.9) | 18 (12.7) |
| Bone scan (%) | 31 (43.7) | 72 (45.0) | 75 (45.7) | 84 (52.8) | 69 (48.3) | 16 (11.3) |
| 68Ga-PSMA PET/CT scan (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.7) | 51 (35.9) |
| Metastases (%) | 1 (1.4) | 0 (0.0) | 2 (1.2) | 5 (3.1) | 7 (4.9) | 4 (2.8) |
68Ga-PSMA PET/CT, (68Ga-prostate specific membrane antigen positron emission tomography/computed tomography); CT, computed tomography.